Foundation Fighting Blindness Retinal Degeneration Fund Ocuphire Pharma, Inc. (OCUP) insider trading activity
Foundation Fighting Blindness Retinal Degeneration Fund is Director of Ocuphire Pharma, Inc.. Currently has a direct ownership of 5.49 Million shares of OCUP, which is worth approximately $5.38 Million. The most recent transaction as insider was on Dec 09, 2025, when has been sold 4,000,000 shares (Common Stock) at a price of $2.15 per share, resulting in proceeds of $8,600,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
5.49M
42.14%
3M change
n/a
12M change
Total Value Held
$5.38 Million
Foundation Fighting Blindness Retinal Degeneration Fund Transaction History
FFB
Foundation Fighting Blindness Retinal Degeneration Fund
Director
Raleigh, NC